Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
96.30
-2.40 (-2.43%)
Sep 9, 2025, 4:08 PM HKT
-2.43%
Market Cap41.25B
Revenue (ttm)6.90B
Net Income (ttm)1.17B
Shares Outn/a
EPS (ttm)3.26
PE Ratio35.27
Forward PE28.70
Dividend1.20 (1.26%)
Ex-Dividend DateJun 25, 2025
Volume532,700
Average Volume879,988
Open99.00
Previous Close98.70
Day's Range95.45 - 99.50
52-Week Range37.60 - 116.60
Beta0.27
RSI52.05
Earnings DateAug 26, 2025

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9,595
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6821
Full Company Profile

Financial Performance

In 2024, HKG:6821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.